{"id":"W1969320029","doi":"10.1007/s00280-010-1530-7","title":"A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients","year":2010,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Charles-Le Moyne; Jewish General Hospital","funders":"Novartis Pharmaceuticals Canada","keywords":"Chlorambucil; Imatinib; Medicine; Fludarabine; Imatinib mesylate; Chronic lymphocytic leukemia; Tyrosine-kinase inhibitor; Pharmacology; Internal medicine; Chemotherapy; Leukemia; Gastroenterology; Oncology; Cancer; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001421343,0.001505218,0.0034586,0.0007405225,0.00075644,0.001165115,0.001047024,0.001344091,0.00312438],"category_scores_gemma":[0.001042804,0.0008375376,0.002047009,0.0007982962,0.001475729,0.00131071,0.0004824766,0.003656299,0.0008157522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001209726,"about_ca_system_score_gemma":0.001852626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002189806,"about_ca_topic_score_gemma":0.004835744,"domain_scores_codex":[0.9992508,0.0003561421,0.0000377686,0.0001263377,0.0000449217,0.0001839832],"domain_scores_gemma":[0.9989393,0.0001923023,0.0001438341,0.00008474685,0.0000443774,0.000595297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8143456,0.06898522,0.008938941,0.00063336,0.001792991,0.0005430314,0.0003825256,0.001992234,0.03463923,0.0002912348,0.002150369,0.06530528],"study_design_scores_gemma":[0.470995,0.5084196,0.01424395,0.00003220183,0.0006784793,0.0003035913,0.0001048735,0.0005774213,0.002163817,0.0001001712,0.002344393,0.00003654138],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936463,0.002776708,0.0002857832,0.0004363918,0.0001342075,0.0009402714,0.0004787559,0.00004775178,0.001253903],"genre_scores_gemma":[0.9923114,0.00263184,0.0006542307,0.0005700324,0.0002433952,0.001117157,0.001169359,0.00002342401,0.001279084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0034586,"threshold_uncertainty_score":0.01045209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0152859007704815,"score_gpt":0.3521121000178381,"score_spread":0.3368261992473566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}